• Pharma Events
• Chemicals Events
• Press Releases
  • 19 May 2010
  • 29 March 2010
  • 15 March 2010
  • 15 March 2010
  • 5 March 2010
  • 26 February 2010
  • 23 February 2010
  • 16 December 2009
  • 6 November 2009
  • 15 October 2009
  • 11 December 2009
  • 09 Juli 2009
  • 09 July 2009
  • 29 June 2009
  • 24 June 2009
  • 19 June 2009
  • 22 January 2009
  • 21 January 2009
  • 21 Januari 2009
  • 2008
  • 2007

Avantium successfully delivers Solid State Research Workflow to Daiichi Sankyo

Avantium announced today that, in partnership with Mitsubishi Corporation, it has entered into a technology transfer agreement with Daiichi Sankyo Company Limited. Under this agreement Avantium supplies its proprietary High Throughput Solid State Research Workflow to Daiichi Sankyo. This workflow consists of a set of modules that enable a very efficient and effective process for screening pharmaceutical compounds to identify novel solid forms: automated solvent selection, high throughput crystallizers, high throughput X-ray analysisand data interpretation.

"Avantium's proven results with this workflow and its scientific expertise in the field of solid state research will help Daiichi Sankyo with its stated mission To create first-in-class and best-in-class drugs." - quote from Mr. Yuki Sato, Executive Officer of Daiichi Sankyo.

"Avantium is very proud to make its technology and know-how available to the global pharma innovator Daiichi Sankyo in the form of our Solid State Research Workflow. Through our partnership with Mitsubishi Corporation we are able to ensure our Japanese customers high level local support," commented Guus Scheefhals, Chief Operating Officer of Avantium Pharma.

Avantium specializes in rational design high-throughput methodologies that enable scientists to conduct carefully selected parallel experiments on a very small scale, under controlled conditions and at a very high speed. The technology transfer focuses on the fast and effective preparation and identification of polymorphs, solvates and salts of pharmaceutical compounds. Avantium is proud to have partnered with Mitsubishi Corporation, which will take care of all local support and first line maintenance.

About Avantium
Avantium is a leading technology company in the area of advanced high-throughput R&D operating in the energy, chemicals and pharmaceutical industries. The company develops products and processes in the area of biofuels, bio-based chemicals and novel crystal forms of existing drugs by applying its proprietary, high-throughput R&D technology.

Avantium has demonstrated the potential of this technology by providing R&D services and systems to more than 70 companies worldwide. Avantium's customer base includes many of the world's largest energy, chemicals and pharmaceutical companies, such as BP, Shell, Sasol, Pfizer and GSK. Avantium has more than 100 employees; its offices and head quarters are based in Amsterdam, The Netherlands.

For more information
Please contact Mariëtte Hoogendoorn at +31 20 586 8010